We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.49B
AUM Growth
-$91.2M
Cap. Flow
-$150M
Cap. Flow %
-2.31%
Top 10 Hldgs %
18.45%
Holding
1,603
New
478
Increased
239
Reduced
260
Closed
489

Sector Composition

Rank Sector Weight
1 Communication Services 3.18%
2 Healthcare 3.02%
3 Financials 2.03%
4 Technology 1.9%
5 Consumer Discretionary 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HR icon
126
CALL
Healthcare Realty
HR
$7.28B
$11.4M 0.18%
+693,400
New +$10.6M
NRG icon
127
PUT
NRG Energy
NRG
$28.3B
$11.4M 0.18%
146,500
+60,200
+70% +$4.66M
TAL icon
128
CALL
TAL Education Group
TAL
$6.93B
$11.3M 0.17%
+1,061,300
New +$12.5M
FANG icon
129
CALL
Diamondback Energy
FANG
$57.1B
$11M 0.17%
+54,700
New +$10.9M
CYTK icon
130
PUT
Cytokinetics
CYTK
$10.5B
$10.8M 0.17%
200,000
-603,500
-75% -$36.4M
UTHR icon
131
CALL
United Therapeutics
UTHR
$25.8B
$10.8M 0.17%
+34,000
New +$9M
DLTR icon
132
PUT
Dollar Tree
DLTR
$24.4B
$10.7M 0.16%
+100,000
New +$11.8M
CERE
133
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$10.6M 0.16%
+260,000
New +$10.8M
RH icon
134
CALL
RH
RH
$3.13B
$10.3M 0.16%
+42,300
New +$11.1M
BEKE icon
135
CALL
KE Holdings
BEKE
$18.7B
$10.3M 0.16%
+730,000
New +$11.4M
BBIO icon
136
BridgeBio Pharma
BBIO
$15.7B
$10.3M 0.16%
406,000
+95,566
+31% +$2.61M
LNTH icon
137
PUT
Lantheus
LNTH
$6.49B
$10.2M 0.16%
+127,600
New +$9.36M
BHC icon
138
PUT
Bausch Health
BHC
$2.58B
$10.2M 0.16%
1,463,600
-151,800
-9% -$1.15M
TEVA icon
139
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$10.2M 0.16%
625,000
+541,300
+647% +$8.34M
DBRG icon
140
CALL
DigitalBridge
DBRG
$2.93B
$9.9M 0.15%
722,900
+164,300
+29% +$2.48M
RTO icon
141
Rentokil
RTO
$11.8B
$9.75M 0.15%
328,870
+96,170
+41% +$2.67M
FCX icon
142
PUT
Freeport-McMoran
FCX
$90B
$9.72M 0.15%
200,000
+150,500
+304% +$7.58M
RTO icon
143
PUT
Rentokil
RTO
$11.8B
$9.64M 0.15%
325,000
-123,000
-27% -$3.41M
ZS icon
144
CALL
Zscaler
ZS
$24.5B
$9.61M 0.15%
+50,000
New +$8.9M
ZS icon
145
PUT
Zscaler
ZS
$24.5B
$9.61M 0.15%
+50,000
New +$8.9M
VSTO
146
CALL
DELISTED
Vista Outdoor Inc.
VSTO
$9.41M 0.14%
250,000
-100,000
-29% -$3.45M
NUGT icon
147
PUT
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$848M
$9.39M 0.14%
250,000
-32,700
-12% -$1.29M
XBI icon
148
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$9.27M 0.14%
100,000
-100,000
-50% -$8.97M
CLF icon
149
CALL
Cleveland-Cliffs
CLF
$6.57B
$9.23M 0.14%
+600,000
New +$10.7M
OSCR icon
150
PUT
Oscar Health
OSCR
$9.41B
$9.22M 0.14%
583,000
+350,000
+150% +$6.43M

Similar funds

Caption Management's Q2 2024 Portfolio in Review

As of Q2 2024, Caption Management held 1,603 positions worth $6.49B, down 1.4% from $6.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management's Q2 2024 filing shows 478 new, 239 increased, 260 reduced and 489 closed positions. Its largest new stake was Alphabet (Google) Class C: 233,700 shares worth $42.9M. The largest sale was Meta Platforms (Facebook), an estimated $25.5M.

By sector, the portfolio is most concentrated in Communication Services at 3.2% of assets, up from 2.6% a quarter earlier, followed by Healthcare and Financials.

  • Caption Management's largest Q2 2024 buy was Alphabet (Google) Class C: 233,700 shares worth $42.9M.
  • Caption Management added most to First Solar in Q2 2024, an estimated $18.5M increase.
  • Caption Management's biggest Q2 2024 reduction was Intra-Cellular Therapies Inc., cutting an estimated $18.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2024.
  • Caption Management opened 478 new positions and closed 489 in Q2 2024.
  • Caption Management's portfolio value fell 1.4% quarter-over-quarter to $6.49B.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.